Anavex Life Sciences Corp (AVXL)

[doingmybest]

Isn't the elephant in the room the lack of direct mention of the status of the phase 2A part b 12 week data? From a timing perspective the last patient should have been in for cognitive testing early Feb. That does not allow a lot of time but sufficient time to generate the data given the fact that the patients' schedules are so stretched out and there is no data crunch to manage. Either the data (at least top line data) is not ready, which seems odd in this situation, or, there is a reason not to present it yet. Everything in today's release is positive, but, the missing piece is the main anticipated piece. I found it interesting, though it could be meaningless, that the wording in the announcement is "The company will also present...". Why the word also, seems odd since the prior paragraph discusses the extension and feedback attained, and, not the upcoming presentation. So, is the word also used just without thought, as a connector, or, does mean that there will be other data presented too? Or, am I totally trying to read too much into it given the desire to see 12 wk data?